Sakar Healthcare Stock Surges 350% in 5 Years on Strong Profit Growth
Source: Mint Markets
Wealth-Impact Simulator
See what a one-time investment could grow to.
Indicative estimate for education only — not investment advice.
Explore investmentsSakar Healthcare's share price saw a significant jump, trading at ₹817.45 today, following a 120% year-on-year rise in net profit for Q1 FY27. The stock has delivered a remarkable 350% return over the past five years.
- ▸Sakar Healthcare stock is trading higher after reporting a 120% profit jump in Q1 FY27.
- ▸The stock has delivered a 350% return over the last five years.
- ▸The company's strong financial performance has led to significant shareholder value creation.
- ✓Sakar Healthcare stock is trading higher after reporting a 120% profit jump in Q1 FY27.
- ✓The stock has delivered a 350% return over the last five years.
- ✓The company's strong financial performance has led to significant shareholder value creation.
Sakar Healthcare's stock opened at ₹817.45 today, up from its previous close of ₹802.20, reaching an intraday high of ₹833.90 on July 27. This surge follows the company's impressive financial results, which reported a 120% year-on-year increase in net profit for the first quarter of the fiscal year 2027 (Q1 FY27).
Over the last five years, Sakar Healthcare has demonstrated exceptional growth, with its share price rallying by approximately 350%. This sustained performance indicates strong investor confidence and robust operational execution by the company.
The company's financial performance in Q1 FY27 highlights its ability to significantly boost profitability. While specific figures for the net profit amount were not provided in the source material, the percentage increase suggests a substantial improvement in earnings.
Investors in Sakar Healthcare have benefited from this upward trend. The stock's consistent rally over half a decade points to its status as a multibagger, rewarding early investors with substantial returns. The recent profit jump is likely to further fuel interest in the stock.
This article is for informational purposes only and does not constitute investment advice.
Community Pulse · This story
How readers rate the outlook after reading this article. Anonymous · one vote per reader · updates live.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.
Frequently Asked Questions
What is Sakar Healthcare's recent stock performance?
Sakar Healthcare's stock opened at ₹817.45 today, up from ₹802.20, and reached an intraday high of ₹833.90 on July 27. It has rallied 350% in five years.
Why has Sakar Healthcare's stock seen a surge?
The stock surge is attributed to the company reporting a 120% year-on-year rise in net profit for Q1 FY27.
What does a 'multibagger' stock mean?
A multibagger stock is one that provides returns of more than 100%, significantly multiplying the initial investment.
Join the Arth Vani channels
Daily news summaries, IPO & market alerts on Telegram and WhatsApp.
Because you read about Stock Market
Global Chip Stocks Tumble on China Competition & AI Funding Worries
Major semiconductor stocks like ASML, Samsung Electronics, and SK Hynix saw significant drops today. Concerns over increased competition from China and the sustainability of AI boom funding are weighing on the sector.
GE Vernova: Investors Urged to Look Beyond Wind Sector's Immediate Challenges
A Yahoo Finance (Global) article suggests investors in GE Vernova should consider factors beyond the immediate performance or perceived headwinds in the wind energy sector. However, the specific details and analysis supporting this advice from the original report are not available in the provided source material.
UBS Updates AMD Stock Target Following Key AI Day Signals
Investment bank UBS has revised its stock price target for semiconductor giant Advanced Micro Devices (AMD), in response to signals and developments from the company's recent 'AI Day' event. This move indicates a keen analyst focus on AMD's strategies and product pipeline within the booming artificial intelligence sector, reflecting the dynamic nature of global tech markets.
Related Stories
Global Chip Stocks Tumble on China Competition & AI Funding Worries
Major semiconductor stocks like ASML, Samsung Electronics, and SK Hynix saw significant drops today. Concerns over increased competition from China and the sustainability of AI boom funding are weighing on the sector.
GE Vernova: Investors Urged to Look Beyond Wind Sector's Immediate Challenges
A Yahoo Finance (Global) article suggests investors in GE Vernova should consider factors beyond the immediate performance or perceived headwinds in the wind energy sector. However, the specific details and analysis supporting this advice from the original report are not available in the provided source material.
UBS Updates AMD Stock Target Following Key AI Day Signals
Investment bank UBS has revised its stock price target for semiconductor giant Advanced Micro Devices (AMD), in response to signals and developments from the company's recent 'AI Day' event. This move indicates a keen analyst focus on AMD's strategies and product pipeline within the booming artificial intelligence sector, reflecting the dynamic nature of global tech markets.
Anthropic CEO Clarifies Stance on Open-Weight AI Models Amid Industry Debate
Anthropic CEO Dario Amodei has stated that his company is not advocating for a ban on open-weight AI models. This clarification comes after Anthropic chose not to sign an industry letter last week that supported such models, drawing questions from critics about their position on AI openness.